key: cord-0320115-3vzg0ol7
authors: Etti, M.; Alger, J.; Salas, S. P.; Saggers, R.; Ramdin, T.; Endler, M.; Gemzell-Danielsson, K.; Alfven, T.; Ahmed, Y.; Callejas, A.; Eskenazi, D.; Khalil, A.; Le Doare, K.
title: Global research priorities for COVID-19 in maternal, reproductive and child health: results of an international survey
date: 2021-07-15
journal: nan
DOI: 10.1101/2021.07.13.21260207
sha: aa4dc4bef39988fac877acecef1e61ac02e5184e
doc_id: 320115
cord_uid: 3vzg0ol7

Background The World Health Organization's ''Coordinated Global Research Roadmap: 2019 Novel Coronavirus'' outlined the need for research that focuses on the impact of COVID-19 on pregnant women and children. More than one year after the first reported case, significant knowledge gaps remain, highlighting the need for a coordinated approach. To address this need, the Maternal, Newborn and Child Health Working Group (MNCH WG) of the COVID-19 Clinical Research Coalition conducted an international survey to identify global research priorities for COVID-19 in maternal, reproductive and child health. Method This project was undertaken using a modified Delphi method. An electronic questionnaire was disseminated to clinicians and researchers in three different languages (English, French and Spanish) via MNCH WG affiliated networks. Respondents were asked to select the five most urgent research priorities among a list of 17 identified by the MNCH WG. Analysis of questionnaire data was undertaken to identify key similarities and differences among respondents according to questionnaire language, location and specialty. Following elimination of the seven lowest ranking priorities, the questionnaire was recirculated to the original pool of respondents. Thematic analysis of final questionnaire data was undertaken by the MNCH WG from which four priority research themes emerged. Results Questionnaire 1 was completed by 225 respondents from 29 countries. Questionnaire 2 was returned by 49 respondents. The four priority research themes were 1) access to healthcare during the COVID-19 pandemic, 2) the direct and 3) indirect effects of COVID-19 on pregnant and breastfeeding women and children and 4) the transmission of COVID-19 and protection from infection. Conclusion The results of these questionnaires indicated a high level of concordance among continents and specialties regarding priority research themes. This prioritized list of research uncertainties, developed to specifically highlight the most urgent clinical needs as perceived by healthcare professionals and researchers, could help funding organizations and researchers to answer the most pressing questions for clinicians and public health professionals during the pandemic. It is hoped that these identified priority research themes can help focus the discussion regarding the allocation of limited resources to enhance COVID-19 research in MNCH globally.

More than one year has passed since the first case of COVID- 19 producing findings that may not be relevant or generalizable to women and children in low-and middle-income countries (LMICs). Furthermore, health systems and public health strategies used to control the spread of the virus in different parts of the world may vary according to the availability of funding and resources, meaning a "one-size-fits-all" approach cannot be appropriately applied to determine research priorities in different global regions. (2, 3) In light of these varying needs, it is imperative that we strive to understand priorities in different international regions. Such an approach is necessary to target funding, resources and research efforts where needed, and to guide policy makers to ensure that efforts are made to address the most pressing research questions for pregnant women and children. To address these needs, the Maternal, Newborn and Child Health Working Group (MNCH WG) of the COVID-19 Clinical Research Coalition, which is comprised of obstetricians, gynecologists, public health physicians and pediatricians, conducted an international survey to identify the most pressing COVID-19 research priorities in maternal, reproductive and child health. (4) In pursuing this line of work, we sought to identify priorities that were equitable, internationally representative, and also representative of the diverse specialties caring for pregnant women and children globally. We also sought to complement other COVID-19 research priority setting exercises currently being undertaken in this field, (5, 6) in order to provide a broader insight into the needs of women and children around the world.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ;  https://doi.org/10.1101/2021.07. 13.21260207 doi: medRxiv preprint This project was undertaken between October 2020 and January 2021 using a modified Delphi method (Figure 1) . A short online questionnaire was designed by the MNCH WG through collaborative discussions guided by the WHO's "Coordinated Global Research Roadmap for the Novel Coronavirus". (1) Questionnaire respondents were asked to provide demographic information including specialty and location, and to select the five most urgent research priorities among a list of 17 which had been generated by the MNCH WG through literature review and expert opinion (Appendix 1). Space was also provided within the questionnaire for respondents to include additional research priorities that were not included in the list. The questionnaire was translated from English into French and Spanish and disseminated electronically using the SurveyMonkey platform via affiliated networks of the MNCH WG 

The frequency of selection of each research priority was calculated (with each research priority being equally weighted). Subgroup analysis of Questionnaire 1 data was performed to determine the frequency of selection of each research priority according to questionnaire language, respondent specialty and respondent location (continent). An overview of additional research priorities submitted by respondents . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint was also undertaken by the MNCH WG to determine whether they were sufficiently distinct from the original listed priorities (no new priorities were added). Following this review, the seven least frequently selected research priorities by questionnaire respondents among the original list of 17 (as indicated by the seven lowest scores) were eliminated from the list, leaving ten research priorities which were reviewed and refined from the MNCH WG and recirculated to respondents to Questionnaire 1 who had consented to being recontacted (Appendix 2). Respondents were asked to rank these ten research priorities from most to least important (with 1 signifying the most important priority and 10 signifying the least important priority) and to comment on the relevance and comprehensibility of the research priorities. Responses to Questionnaire 2 were also collected over a period of four weeks. The mean ranking of each research priority was calculated by dividing the sum of the rankings for each research priority by the total number of respondents to Questionnaire 2. We subsequently performed a thematic analysis of the most frequently selected priorities from Questionnaire 1 and the highest ranked priorities among Questionnaire 2, through which four principal research priority themes emerged. The MNCH WG reconvened to define important research questions within each theme. Three key questions within each research priority theme were developed following literature review to identify persisting knowledge gaps. We then presented the research questions to OBGYN and pediatric specialists at virtual international meetings to ensure agreement among specialists within the field.

This project was reviewed by the Public Health England Research Ethics and Governance Group. Given the consultative nature of the surveys, the project was deemed not to require full ethical review and was granted an exemption from the ethical approval process (https://www.gov.uk/government/organisations/publichealth-england/about/research).

Questionnaire 1 was completed by 225 respondents from 29 countries across five continents ( Figure 2 ). The full list of countries can be found in Appendix 3. The demographic characteristics of Questionnaire 1 respondents and most frequently . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint selected research priorities according to questionnaire language, respondent specialty and location are shown in Table 1 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint

The advent of the COVID-19 pandemic has seen unprecedented amounts of pressure being placed on healthcare systems around the world. Acute and critical care services in many countries have been overstretched, leading to the redeployment of many healthcare professionals to the front line and causing a reduction in the provision of "non-urgent" services. In light of this, we must examine what effect these changes have had on women and children their ability to access maternal, sexual and reproductive and child healthcare services during this time. This is particularly pertinent for vulnerable members of society including adolescent girls and unmarried women among migrant and refugee populations who were already facing challenges in accessing these services prior to the onset of the pandemic.(11) Access to healthcare for children during the COVID-19 pandemic was the research priority with the highest average ranking in Questionnaire 2. Evaluating access to maternal and sexual health services for women in vulnerable groups was the most frequently selected research priority among questionnaire respondents based in Africa and was the second most frequently selected research priority among respondents from all other regions, which may reflect concern for a worsening of the pre-existing challenges in the provision of healthcare services that exist due to vast socioeconomic inequalities in many parts of the world. (12) The inclusion of pregnant and breastfeeding women in COVID-19 vaccine trials was the most frequently selected priority by North American respondents and the fifth most frequently selected research priority among infectious disease specialists who responded to Questionnaire 1. Throughout 2020, pregnant and breastfeeding women were systematically excluded from most COVID-19 treatment and vaccine trials despite urgent calls for their inclusion. (13) Concerns around the lack of safety data also meant that pregnant and breastfeeding women were not prioritized to receive the vaccines after their approval, despite evidence that pregnant women were of greater risk of disease complications. (14, 15) In April 2021, the United States Centers for Disease Control and Prevention (US CDC) announced that pregnant and breastfeeding women could safely receive these vaccines after real world data from more than 90,000 pregnant women did not identify any safety signals, however, this came five months after these vaccine were authorized for use in non-pregnant adults. (16) (17) (18) (19) While some interventional studies, such as the RECOVERY trial, had . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. America. Data from the US CDC has shown that pregnant women are at greater risk of intensive care unit admission and death due to COVID-19 than non-pregnant women, and early research suggests that poorer birth outcomes will likely be more prevalent among pregnant women from vulnerable populations within LMICs. (14, 15, (22) (23) (24) Additional observational studies have also identified that women diagnosed with COVID-19 during pregnancy are at higher risk for preeclampsia, preterm birth and stillbirth than women who did not have COVID-19 during their pregnancy. (14, 25, 26) The increased severity of illness among pregnant . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. Understanding the risk and routes of transmission of any communicable disease is essential for controlling its spread. Identifying the potential routes of mother-to-childtransmission of COVID-19 is of particular importance for healthcare professionals to be able to provide appropriate care and advice for pregnant and breastfeeding women to minimize the risks posed to their infant. It is well known that some viral infections during pregnancy can have devastating effects on the developing fetus, yet there have been few large-scale studies which involve the collection of samples from pregnant women infected with COVID-19 to determine the routes through which the virus, and immunity to the virus, can be passed from mother to child. There is emerging evidence that suggests that maternally-derived IgG antibodies against the SARS-CoV-2 virus can be transferred to the developing fetus transplacentally. (41) There is also evidence that IgA antibodies against the SARS-CoV-2 virus can also found in the breastmilk, although it is not yet determined whether this is sufficient to confer immunity against COVID-19.(42) These data are urgently needed to better inform . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

There was an over-representation of Central and South American respondents among the responses to Questionnaire 1. We sought to obtain as many responses from as diverse a group of respondents as possible, however, it is likely that the questionnaire was more successfully disseminated via networks in this region compared to other parts of the world. There was also a preponderance of pediatric infectious diseases . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint societies among the networks through which Questionnaire 1 was disseminated, which may have skewed responses received towards pediatric infectious diseases specialists. We chose to disseminate the questionnaires through affiliated memberships of the working group members and via social media as we believed this would allow a greater inclusion of clinicians and frontline workers as well as researchers in resource-limited nations. In disseminating the questionnaires using these links, it is possible that our results may have been subject to sampling bias. To mitigate the effect of these potential biases, we performed a subgroup analysis to ensure that the views of respondents from all regions and specialties were equitably reflected among the final list of research priority themes.

There was also a significantly reduced response rate to Questionnaire 2 (21.7% of the original pool of respondents), possibly as the dissemination of our second questionnaire coincided with the second wave of the COVID-19 pandemic in many of the countries where our respondents were based. (48) (49) (50) This reduction in engagement may have therefore reflected local challenges faced by the clinicians and researchers due to an increasing number of COVID-19 cases, although we cannot exclude other causes for this reduced response rate. Given the degree of attrition, we considered the subgroup preferences from Questionnaire 1 when developing the final research priority themes to ensure parity among responses and to lessen the influence of the reduction in response rate on the final research priorities derived from the questionnaire data. In light of the low response rate to Questionnaire 2, it was also decided that a modified Delphi approach would be used with only two questionnaire rounds. Given that there was a high degree of consensus among the answers to Questionnaire 1, we believe this method remained appropriate for the development of these four research priority themes.

Although space was provided for additional comments from respondents, the use of questionnaires imposed limitations on the depth of the data we were able to collect.

While the questionnaires were useful for collecting data from a large number of professionals within our target field, we were limited in our ability to further explore the response we received. Future work may require a more in-depth exploration of ideas through interviews and focus group discussions with respondents to further . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

No interests declared . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint 1 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 15, 2021. ; Average ranking . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 15, 2021. ; https://doi.org/10.1101/2021.07.13.21260207 doi: medRxiv preprint *Questionnaire respondents were permitted to select more than one specialty therefore the percentage total is >100%

Novel Coronavirus

The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19

COVID-19 en América Latina y Caribe: Determinación de prioridades en investigación y llamado a la acción

Newborn & Child Health | COVID-19 Clinical Research Coalition

Shifting research priorities in maternal and child health in the COVID-19 pandemic era in India: a renewed focus on systems strengthening

Sexual and reproductive health and rights of refugee and migrant women: gynecologists' and obstetricians' responsibilities

COVID-19 and health care inaccessibility in sub-Saharan Africa

The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and metaanalysis

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study

Interim Clinical Considerations for Use of COVID-19 Vaccines | CDC

Preliminary Findings of mRNA Covid-19 Vaccine 1

Safety in Pregnant Persons

Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women | Pfizer

Inclusion of pregnant women in clinical trials of COVID-19 therapies: what have we learned?

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States

Are clinical outcomes worse for pregnant women at ≥ 20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching

Pregnant Women in Low-and Middle-Income Countries Require a Special Focus During the COVID-19 Pandemic. Frontiers in Global Women's Health

Association of SARS-CoV-2 Test Status and Pregnancy Outcomes

Preterm Birth and Stillbirth During the COVID-19 Pandemic in Sweden: A Nationwide Cohort Study

Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet

COVID-19 testing in Africa: lessons learnt. The Lancet Microbe

A call for action for COVID-19 surveillance and research during pregnancy

COVID-19: Neurological Considerations in Neonates and Children

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multicentre observational cohort 1 8 study

Multisystem inflammatory syndrome in children in South Africa

Childhood Multisystem Inflammatory Syndrome -A New Challenge in the Pandemic

Gender-Based Violence, Twin Pandemic to COVID-19

Moms Are Not OK: COVID-19 and Maternal Mental Health. Frontiers in Global Women's Health

Women's mental health: acute impact of COVID-19 pandemic on domestic violence

The Lancet Infectious Diseases. The intersection of COVID-19 and mental health

Child Healthcare and Immunizations in Sub-Saharan Africa During the COVID-19 Pandemic

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

Pandemic Threatens to Push 72 Million More Children into Learning Poverty-World Bank outlines a New Vision to ensure that every child learns, everywhere

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

SARS-CoV-2 genome and antibodies in breastmilk: A systematic review and meta-analysis

COVID-19 and opportunities for international cooperation in health

An international registry for emergent pathogens and pregnancy

ALERRT -African coaLition for Epidemic Research Response and Training

The first and second waves of the COVID-19 pandemic in Africa: a crosssectional study

Your specialty: • Obstetrics and Gynecology • Pediatrics • Sexual and Reproductive Health • Midwifery and Nursing • Infectious Diseases/Pathological Sciences • Public Health • Epidemiology • Other

Are you currently involved in research related to COVID-19? Y/N a. If yes, what is your main area of focus?

Access to maternal, sexual and reproductive healthcare among vulnerable groups during the COVID-19 pandemic • Access to healthcare for children during the COVID-19 pandemic • Direct impact of COVID-19 on pregnant and infant populations • Immunological mechanisms of resilience against COVID-19 among children • Inclusion of pregnant women in COVID-19 vaccine trials • Inclusion of pregnant and breastfeeding women in COVID-19 treatment trials • Indirect effects of the COVID-19 pandemic on pregnant and infant populations • Infection prevention and control • Mental health sequelae of COVID-19 pandemic in pregnancy

• Pathophysiology and long term sequelae of pediatric inflammation and multisystem syndrome

• Pathophysiological mechanisms of severe disease in children • Potential aerosolization of SARS-CoV-2 during second stage of labor • Prevention and treatment strategies for pregnant women and newborns in humanitarian settings • Safe breastfeeding

The Maternal, Newborn and Child Health (MNCH) Working Group of the COVID- 19 Clinical Research Coalition would like to seek your opinion about priority research areas relating to COVID-19 and MNCH. We would be grateful for your answers to the questions in this short survey. Thank you.

Thank you for agreeing to be contacted about the results of the MNCH Research Priorities questionnaire sent by the COVID-19 Clinical Research Coalition earlier this year.We have reviewed the responses of the first questionnaire and identified the highest ranked research priorities. We would be grateful for additional feedback to refine these priorities further. Thank you.